Form D · Other Technology
Ordway Labs, Inc.
Washington, DC · CIK 0001744286
Offering snapshot reported Feb 21, 2020 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Feb 7, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2020 | Initial | $10,000,000 | No comparison | 4 | SEC filing |
| Jun 21, 2018 | Initial | $2,500,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-361114
This filing covers the sale and issuance of Series A Preferred Stock and the underlying Common Stock issuable upon conversion thereof.
Source: Form D, filed Feb 21, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Izhar Armony | Director |
| Sameer Gulati | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1707 L Street Nw Suite 850
Washington, DC, 20036
Washington, DC, 20036